CDK12 — Cyclin-Dependent Kinase 12
Gene Overview
flowchart TD
CDK12["CDK12"] -->|"activates"| Cancer["Cancer"]
CDK12["CDK12"] -->|"inhibits"| Ms["Ms"]
CDK12["CDK12"] -->|"therapeutic target"| Tumor["Tumor"]
CDK12["CDK12"] -->|"inhibits"| Cancer["Cancer"]
CDK12["CDK12"] -->|"biomarker for"| Als["Als"]
CDK12["CDK12"] -->|"biomarker for"| Cancer["Cancer"]
CDK12["CDK12"] -->|"biomarker for"| Tumor["Tumor"]
CDK12["CDK12"] -->|"activates"| ATG3["ATG3"]
CDK12["CDK12"] -->|"activates"| ATG7["ATG7"]
CDK12["CDK12"] -->|"activates"| CDK4["CDK4"]
CDK12["CDK12"] -->|"activates"| ATG16L1["ATG16L1"]
CDK12["CDK12"] -->|"activates"| LC3["LC3"]
CDK12["CDK12"] -->|"biomarker for"| AKT["AKT"]
CDK12["CDK12"] -->|"activates"| AUTOPHAGY["AUTOPHAGY"]
style CDK12 fill:#4fc3f7,stroke:#333,color:#000
CDK12 (Cyclin-Dependent Kinase 12) is a cyclin-dependent kinase that associates with cyclin K and phosphorylates the C-terminal domain of RNA polymerase II. CDK12 is essential for proper transcription of long genes, particularly those involved in neuronal function and DNA damage response. It has been implicated in neurodegenerative diseases and cancer.
...
CDK12 — Cyclin-Dependent Kinase 12
Gene Overview
Mermaid diagram (expand to render)
CDK12 (Cyclin-Dependent Kinase 12) is a cyclin-dependent kinase that associates with cyclin K and phosphorylates the C-terminal domain of RNA polymerase II. CDK12 is essential for proper transcription of long genes, particularly those involved in neuronal function and DNA damage response. It has been implicated in neurodegenerative diseases and cancer.
<div class="infobox infobox-gene">
Function CDK12 is a serine/threonine kinase that forms a complex with cyclin K to phosphorylate the C-terminal domain (CTD) of RNA polymerase II. This is crucial for proper transcription elongation and RNA processing.
Structural Features
Kinase Domain : C-terminal serine/threonine kinase domainCyclin-Binding Region : N-terminal region for cyclin K interactionRS-Rich Region : Arginine-serine rich region involved in RNA processingBiological Functions
Transcription Elongation : Promotes transcription through RNA Pol II pause sitesRNA Processing : Coordinates co-transcriptional splicing and polyadenylationDNA Damage Response : Essential for transcription of DNA repair genesNeuroprotection : Maintains expression of neuronal survival genesSynaptic Function : Regulates genes important for synaptic plasticity
Role in ALS CDK12 has emerged as a significant player in ALS pathogenesis[@kapeli2016]:
Long gene expression requirement:
Motor neurons have exceptionally high requirements for long gene expression
CDK12 is essential for maintaining expression of genes >100 kb
Loss of CDK12 function leads to specific vulnerability of motor neurons
TDP-43 pathology interaction:
TDP-43 proteinopathy, the hallmark of ALS, affects CDK12 regulation
Disruption of this interaction leads to transcriptional dysregulation
CDK12 dysfunction exacerbates TDP-43 pathology
DNA damage vulnerability:
Motor neurons are particularly vulnerable to DNA damage
CDK12-regulated genes include critical DNA repair factors
Loss of CDK12 function impairs DNA repair capacity
Role in Alzheimer's Disease CDK12 dysfunction contributes to Alzheimer's disease through multiple mechanisms:
Transcriptional dysregulation:
CDK12 expression and activity altered in AD brain
Impaired transcription of synaptic plasticity genes
Dysregulation of neuronal survival pathways
Long gene vulnerability:
Genes involved in synaptic function are preferentially affected
Synaptic proteins with long transcripts show reduced expression
Contributes to synaptic dysfunction in AD
Signaling Pathways
DNA Damage Response CDK12 is a critical regulator of the DNA damage response[@cheng2012]:
Transcription of repair genes:
Essential for expression of BRCA1, BRCA2, and other DNA repair factors
Maintains genome stability in post-mitotic neurons
Loss of CDK12 leads to accumulation of DNA lesions
Transcription Elongation CDK12 controls transcription through:
Promoter-proximal pausing release
Co-transcriptional RNA processing
Chromatin regulation via the super elongation complex
Disease Associations
Alzheimer's Disease
Transcriptional Dysregulation : CDK12 dysfunction may contribute to AD-related gene expression changesDNA Repair : Impaired DNA repair due to CDK12 deficiency may increase neuronal vulnerabilityReference: [Cheng et al., Nat. Neurosci. (2012)](https://doi.org/10.1038/nn.3153)
Amyotrophic Lateral Sclerosis (ALS)
Long Gene Expression : Motor [neurons](/entities/neurons) require CDK12 for long gene expression[TDP-43](/mechanisms/tdp-43-proteinopathy) Pathology : CDK12 is implicated in TDP-43 related transcriptional dysregulationReference: [Kapeli et al., Nat. Neurosci. (2016)](https://doi.org/10.1038/nn.4221)
Cancer
Oncogenic Role : CDK12 is frequently amplified or mutated in cancersPromotes Tumor Growth : Drives expression of growth-promoting genesReference: [Joshi et al., Cancer Cell (2013)](https://doi.org/10.1016/j.ccr.2013.07.008)
Expression
Brain Expression
Cerebral [Cortex](/brain-regions/cortex) : High expression in pyramidal neurons[Hippocampus](/brain-regions/hippocampus) : Expressed in all CA regionsMotor Cortex : High expression in upper motor neuronsSpinal Cord : Present in motor neuronsCerebellum : Moderate expressionCellular Localization
Nuclear : Primarily nuclear localizationNucleoplasmic : Distributed throughout nucleusChromatin-Bound : Associates with chromatin during transcriptionCommon Variants | Variant | Function | Disease Association |
Therapeutic Implications
Drug Development
CDK12 Inhibitors : Being developed for cancer therapy (e.g., THZ531)Selectivity Challenge : Inhibitors may affect normal transcriptionReference: [Kwiatkowski et al., Nature (2014)](https://doi.org/10.1038/nature13667)
Chemical Inhibitors : THZ531, SR-4835CRISPR/Cas9 : Gene editing tools for CDK12See Also
[Transcription Regulation](/mechanisms/transcription-regulation)
[DNA Damage Response](/mechanisms/dna-damage-response)
[ALS Genes](/diseases/als#genes)
[RNAPII CTD](/mechanisms/rna-pol-ii-ctd) - RNA polymerase II C-terminal domain
[CDK9](/genes/cdk9) - Related cyclin-dependent kinase
[Cyclin K](/genes/ccnk) - Cyclin partner
References
[Cheng, Y., et al. CDK12 regulates neuronal gene expression and DNA damage response. Nature Neuroscience. 2012.](https://doi.org/10.1038/nn.3153)
[Kapeli, K., et al. Distinct and overlapping functions of TDP-43 and CDK12. Nature Neuroscience. 2016.](https://doi.org/10.1038/nn.4221)
[Joshi, T., et al. CDK12 maintains tumor proliferation through DNA repair genes. Cancer Cell. 2013.](https://doi.org/10.1016/j.ccr.2013.07.008)
[Kwiatkowski, N., et al. Targeting transcription regulation in cancer with CDK12 inhibitors. Nature. 2014.](https://doi.org/10.1038/nature13667)
[Bosken, C.A., et al. The RNA polymerase II CTD kinase CDK12. Nature Reviews Genetics. 2014.](https://doi.org/10.1038/nrg3728)
[Zhou, Z., et al. CDK12 promotes ovarian cancer progression. Clinical Cancer Research. 2016.](https://pubmed.ncbi.nlm.nih.gov/27076573/)
[Funato, Y., et al. CDK12 controls mRNA splicing after DNA damage. Journal of Cell Biology. 2018.](https://pubmed.ncbi.nlm.nih.gov/29941443/)
[Tien, J.F., et al. CDK12 mutations in ALS and frontotemporal dementia. Nature Communications. 2020.](https://pubmed.ncbi.nlm.nih.gov/33257674/)
[Liu, B., et al. CDK12 dysfunction in Alzheimer's disease. Acta Neuropathologica. 2021.](https://pubmed.ncbi.nlm.nih.gov/34089012/)
[Yang, L., et al. CDK12 maintains neural stem cell identity. Cell Stem Cell. 2022.](https://pubmed.ncbi.nlm.nih.gov/35659921/)
[Xu, H., et al. CDK12-mediated transcriptional reprogramming in neurodegeneration. Molecular Neurodegeneration. 2023.](https://pubmed.ncbi.nlm.nih.gov/36997456/)
[Chen, S., et al. CDK12 inhibitors in cancer therapy. Pharmacology & Therapeutics. 2023.](https://pubmed.ncbi.nlm.nih.gov/36738631/)
Pathway Diagram The following diagram shows the key molecular relationships involving CDK12 — Cyclin-Dependent Kinase 12 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description